Search the Newsreel

CECO: Q2 Earnings Snapshot

CECO's Backlog Reaches $1.8B in First Quarter as Combined Company

CECO Environmental reported record second-quarter 2026 results, its first quarter including the June 1 Thermon acquisition, with orders up 191% to $798.5 million and backlog reaching $1.8 billion. Revenue increased 54% to $285.0 million, and adjusted EBITDA rose 73% to $40.2 million. The company …

CECO Environmental Reports Second Quarter 2026 Results

Record-Setting Second Quarter Highlighted by Strong Orders, Up 191 Percent and Backlog Above $1.8 Billion Thermon Integration Delivering Synergies Ahead of Plan Company Raises Full Year Consolidated 2026 Outlook ADDISON, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- CECO Environmental Corp. (Nasdaq: CECO) ("CECO"), a …

Jefferies Financial Group Reiterates Buy Rating for Luceco (LON:LUCE)

CECO Environmental Corp. (NASDAQ:CECO) Given Consensus Recommendation of "Buy" by Brokerages

Brokerages have issued a consensus "Buy" recommendation for CECO Environmental Corp. (NASDAQ:CECO), with an average 12-month price target of $104. The stock opened at $70.92, below its 50-day moving average, and saw mixed insider activity with one director buying and another selling shares. Institutional …

Top Wall Street Forecasters Revamp CECO Environmental Expectations Ahead Of Q2 Earnings

Behavioral Patterns of CECO and Institutional Flows

This article analyzes the behavioral patterns of Ceco Environmental Corp. (NASDAQ: CECO) using AI models, highlighting a positive near-term sentiment within a long-term strength context. It identifies key support and resistance levels and offers three distinct institutional trading strategies: a Position Trading Strategy, a …

IceCure Medical Shareholders Approve Special Meeting Agenda on August 6, 2026

IceCure Medical shareholders approved the sole agenda item at a Special General Meeting held on August 6, 2026, in Caesarea, Israel, after the meeting was reconvened due to a lack of quorum. The company has filed a Form 6-K with the U.S. SEC to …

Icecure Medical Ltd (ICCM) News, Articles, Events & Latest Updates

IceCure Medical (ICCM) is actively expanding its clinical studies and commercial reach for its ProSense cryoablation technology. The company recently added Adventist Health as a U.S. clinical site for its "ChoICE" study for low-risk breast cancer and will report its first-half 2026 financial results …

CECO ENVIRONMENTAL Q2 2026 Earnings Preview: Recent $CECO Insider Trading, Hedge Fund Activity, and More

CECO Environmental is set to release its Q2 2026 earnings on August 10th, with analysts projecting $288.86 million in revenue and $0.31 EPS. The article provides a detailed overview of recent insider trading, institutional holdings, government contracts, congressional stock activity, and analyst ratings for …

IceCure Medical (ICCM) holders approve agenda after adjourned meeting

IceCure Medical Ltd. shareholders approved the agenda item during a Special General Meeting held on August 6, 2026. The meeting was initially adjourned due to a lack of quorum but reconvened later the same day once sufficient shareholder presence was achieved. This information was …

IceCure Medical Adds Adventist Health as U.S. Clinical Site for its Post-Marketing "ChoICE" Study for Low-Risk Breast Cancer Cryoablation Treatment

IceCure Medical has announced that Adventist Health Glendale will be the first U.S. clinical site to enroll patients in its post-marketing "ChoICE" study for ProSense® cryoablation treatment of low-risk breast cancer. The study aims to gather real-world data on up to 400 patients across …

FMR LLC discloses 7.7% CECO Environmental (CECO) ownership in Schedule 13G/A

FMR LLC has reported a beneficial ownership of 7.7% of CECO Environmental Corp common stock, totaling 4,524,438.33 shares as of June 30, 2026. The filing indicates that FMR LLC holds sole dispositive power over these shares and sole voting power over 4,521,770 shares. Abigail …

IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026

IceCure Medical Ltd. announced it will release its financial and operational results for the first half of 2026 on Wednesday, August 12, 2026, before the Nasdaq Stock Market opens. The company, which develops minimally-invasive cryoablation technology, will also host a conference call and webcast …

Arkadios Wealth Advisors Acquires New Position in CECO Environmental Corp. $CECO

Arkadios Wealth Advisors has acquired a new stake in CECO Environmental Corp. (NASDAQ:CECO), purchasing 17,888 shares valued at approximately $1.07 million. Institutional investors collectively own 68.08% of the company, and analysts maintain a "Buy" consensus rating with an average target price of $106.71. Insider …

CECO Environmental set to report first post-Thermon earnings

CECO Environmental is preparing to announce its second-quarter results, marking its first earnings report since acquiring Thermon Group Holdings for $2.2 billion. Analysts anticipate EPS of $0.27 and revenue of $273.67 million, showing significant year-over-year growth, largely driven by the Thermon acquisition. Investors will …

After Thermon Acquisition, CECO’s First Combined Results Are Due Aug. 10

CECO Environmental (NASDAQ: CECO) has rescheduled its Q2 2026 earnings release and conference call from August 6 to August 10, 2026. This change is due to the need for additional time to complete financial reporting and review processes following the acquisition of Thermon Group …

CECO Environmental Announces Rescheduling of Second Quarter

CECO Environmental announced the rescheduling of its second-quarter 2026 earnings call from August 6 to August 10, 2026. This delay is due to the need for additional time to finalize financial reporting and review processes following the acquisition of Thermon Group Holdings, Inc., making …

IceCure Medical Will Discuss Six-Month Results on Aug. 12

IceCure Medical (NASDAQ: ICCM) announced it will release its financial and operational results for the six months ended June 30, 2026, on Wednesday, August 12, 2026, before the Nasdaq Stock Market opens. The company will also host a conference call and live webcast at …

TD Cowen initiates CECO Environmental stock coverage with buy rating

TD Cowen has initiated coverage on CECO Environmental Corp (NASDAQ:CECO) with a buy rating and a price target of $85.00, citing the company's crucial role in global power infrastructure, particularly data centers. This positive outlook follows CECO's recent merger with Thermon Group Holdings, Inc., …

Why Luceco (LSE:LUCE) Is Drawing Fresh Attention Among UK Growth Stocks

Is CECO Environmental’s (CECO) Oversold Signal Masking a Quiet Upgrade in Its Earnings Narrative?

CECO Environmental (CECO) has been flagged as technically oversold, coinciding with analysts raising earnings estimates and assigning a top-tier Zacks Rank, suggesting a potential earnings surprise. Despite this, the article highlights the central tension between CECO's growth ambitions, elevated spending, and leverage. Investors are …

CECO Environmental Number of Employees 2026 | Employee Count & Headcount Data

CECO Environmental (NASDAQ: CECO) reported approximately 1,761 employees worldwide as of March 2026, representing an 8.5% growth since 2023. The company is actively hiring, with 185 active job postings in 2026, despite a 4.7% decline from 2025. North America holds the largest share of …

CECO Environmental Market Sentiment

This article analyzes market sentiment for CECO Environmental (CECO) based on analyst consensus, short interest, options flow, and insider activity. It highlights a "Buy" consensus from 8 analysts with an average price target of $82, a rising short interest of 4.2%, and a bearish …

Luceco PLC Revenue Breakdown – DUS:2LC

Price to book forward of IceCure Medical Ltd. – NASDAQ:ICCM

This page provides financial data for IceCure Medical Ltd. (NASDAQ: ICCM), specifically focusing on its "Price to book forward" metric. The content includes an overview of the company's financials on the Nasdaq Stock Market via TradingView, indicating that the market was closed at the …

Luceco PLC Revenue Breakdown – LSE:LUCE

Ceco Environmental Corp. (CECO) Q3 2024 Earnings Report - Results, Call & Slides

Ceco Environmental Corp. (CECO) released its Q3 2024 earnings report, missing analyst expectations with an actual EPS of $0.14 against a consensus of $0.20, and revenue of $135.51M compared to an expected $155.94M. The company's revenue also saw a year-over-year decline of 9.29%. The …

IceCure Medical Kicks Off its Post-Marketing "ChoICE" Study for the Low-Risk Breast Cancer Treatment at First U.S Clinical Site

IceCure Medical Ltd. has initiated its post-marketing "ChoICE" study for ProSense® cryoablation in treating low-risk breast cancer, with the West Cancer Center & Research Institute in Germantown, Tennessee, as the first U.S. clinical site. The study aims to enroll up to 400 patients across …

Ceconomy AG (MTTRY) (Q3 2026) Earnings Call Highlights: 14th Consecutive Quarter of Profitable ...

This article first appeared on GuruFocus. Revenue (Sales): EUR 18.4 billion in the first nine months, a 5% increase adjusted for currency and portfolio effects. Q3 like-for-like growth was 8.2%. Adjusted EBIT: EUR 342 million in the first nine months, an increase of EUR …

CECO Environmental Corp (CECO) Institutional Confidence

CECO Environmental Corp (CECO) has an institutional shareholding score of 7.00, placing it 74th out of 159 in the Professional & Commercial Services industry. The institutional shareholding proportion is 84.12%, marking a 17.58% decrease quarter-over-quarter. Chuck Royce is the largest institutional shareholder, holding 2.31% …

IceCure's tumor-freezing treatment proposed as breast surgery alternative

The Society of Interventional Oncology (SIO) has petitioned the National Comprehensive Cancer Network (NCCN) to include IceCure Medical's cryoablation treatment, ProSense®, as an alternative to breast-conserving surgery for selected low-risk, early-stage breast cancer patients. This proposal, supported by IceCure's FDA marketing authorization in October …

CECO Environmental (CECO) Stock Could Be 37% Undervalued On Recovery Hopes

IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense®

The Society of Interventional Oncology (SIO) has formally petitioned the National Comprehensive Cancer Network (NCCN) to include percutaneous cryoablation in breast cancer treatment guidelines, specifically for low-risk, early-stage cases. This petition, which seeks to expand eligibility to patients aged 50-69 who are poor surgical …

(CECO) Movement Within Algorithmic Entry Frameworks

This article analyzes Ceco Environmental Corp. (NASDAQ: CECO) using AI models, identifying weak near and mid-term sentiment but a strong long-term outlook. It provides three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis emphasizes elevated …

Earnings Flash (LUCE.L) Luceco PLC Reports H1 Revenue GBP143.0M